Kevlar

DuPont Completes $1.8 Billion Divestiture of Aramids Business

DuPont has completed the sale of its Aramids business, including Kevlar and Nomex brands, to Arclin in a deal valued at about $1.8 billion.

News

DuPont Wins $919 Mln. Kevlar Lawsuit Against Kolon

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Interview

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

DuPont Company

Kevlar

DuPont Completes $1.8 Billion Divestiture of Aramids Business

New Jersey Authority Cites DuPont Unit for 11 Violations

DuPont Wins 20-Year Ban on Kolon's Kevlar Rival

DuPont Sees Protein Demand Lifting Soy Sales

DuPont Starts Up $500 Million Kevlar Facility In South Carolina